Blueprint Medicines Corp (BPMC)

전일 마감가:

$107.00

열려 있는:

$109.82

하루 거래량:

996.08K

시가총액:

$6.71B

수익:

$249.38M

순이익/손실:

$-506.98M

주가수익비율:

-11.66

EPS:

-9.19

순현금흐름:

$-452.91M

1주 성능:

+15.26%

1개월 성능:

+16.22%

6개월 성능:

+79.34%

1년 성능:

+106.61%

1일 변동 폭

$106.07

$110.93

52주 변동 폭

$43.89

$110.93

Blueprint Medicines Corp Stock (BPMC) Company Profile

명칭

Blueprint Medicines Corp

부문

Healthcare (1213)

산업

Biotechnology (699)

전화

617-374-7580

주소

38 Sidney Street, Cambridge, MA

직원

193

트위터

@BlueprintMeds

다음 수익 날짜

2024-05-02

최신 SEC 제출 서류

BPMC's Discussions on Twitter

Blueprint Medicines Corp Stock (BPMC) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-10-27	업그레이드	Oppenheimer	Perform → Outperform
2023-08-21	재확인	Needham	Buy
2023-07-31	업그레이드	Wells Fargo	Equal Weight → Overweight
2023-06-05	다운그레이드	SVB Securities	Market Perform → Underperform
2023-01-03	업그레이드	Wells Fargo	Underweight → Equal Weight
2022-12-14	개시	Needham	Buy
2022-11-02	다운그레이드	Oppenheimer	Outperform → Perform
2022-09-14	개시	Berenberg	Buy
2022-07-08	개시	Oppenheimer	Outperform
2022-06-27	개시	Wells Fargo	Underweight
2022-06-10	다운그레이드	Citigroup	Neutral → Sell
2022-06-01	업그레이드	Jefferies	Hold → Buy
2022-03-01	개시	Citigroup	Neutral
2022-02-17	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2022-01-25	업그레이드	Stifel	Hold → Buy
2021-11-19	재개	Morgan Stanley	Equal-Weight
2021-09-30	재개	Stifel	Hold
2021-06-04	재개	Robert W. Baird	Outperform
2021-03-31	개시	Credit Suisse	Neutral
2020-12-03	개시	Stifel	Hold
2020-11-02	재확인	H.C. Wainwright	Buy
2020-11-02	다운그레이드	Jefferies	Buy → Hold
2020-10-30	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2020-07-15	재확인	H.C. Wainwright	Buy
2020-05-05	개시	Barclays	Equal Weight
2020-03-17	업그레이드	BMO Capital Markets	Market Perform → Outperform
2020-01-28	개시	BMO Capital Markets	Market Perform
2020-01-27	개시	BMO Capital Markets	Market Perform
2019-11-06	업그레이드	Raymond James	Outperform → Strong Buy
2019-10-22	개시	JMP Securities	Mkt Outperform
2019-10-03	개시	H.C. Wainwright	Buy
2019-09-12	업그레이드	Raymond James	Mkt Perform → Outperform
2019-08-29	개시	Piper Jaffray	Neutral
2019-08-15	재개	Raymond James	Mkt Perform
2019-07-18	개시	Deutsche Bank	Buy
2019-05-23	재개	Goldman	Buy
2019-04-03	개시	Morgan Stanley	Overweight
2018-09-25	개시	Leerink Partners	Outperform
2017-12-11	재확인	Goldman	Buy

모두보기

Blueprint Medicines Corp 주식(BPMC)의 최신 뉴스

Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises

Zacks Investment Research

Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates

Zacks Investment Research

Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

Strength in Kidney Care Likely to Aid DaVita's (DVA) Q1 Earnings

Zacks Investment Research

Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store?

Zacks Investment Research

What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?

Zacks Investment Research

Blueprint Medicines Corp (BPMC) 재무 분석

Blueprint Medicines Corp (BPMC) 매출 2024

Blueprint Medicines Corp (BPMC) 순이익 2024

Blueprint Medicines Corp (BPMC) 현금흐름 2024

Blueprint Medicines Corp (BPMC) 주당 순이익 2024